211 related articles for article (PubMed ID: 26541366)
1. MRP1 and its role in anticancer drug resistance.
Lu JF; Pokharel D; Bebawy M
Drug Metab Rev; 2015; 47(4):406-19. PubMed ID: 26541366
[TBL] [Abstract][Full Text] [Related]
2. Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways.
Lu JF; Luk F; Gong J; Jaiswal R; Grau GE; Bebawy M
Pharmacol Res; 2013 Oct; 76():77-83. PubMed ID: 23917219
[TBL] [Abstract][Full Text] [Related]
3. Cellular communication via microparticles: role in transfer of multidrug resistance in cancer.
Jaiswal R; Raymond Grau GE; Bebawy M
Future Oncol; 2014 Mar; 10(4):655-69. PubMed ID: 24754595
[TBL] [Abstract][Full Text] [Related]
4. Microparticles and their emerging role in cancer multidrug resistance.
Gong J; Jaiswal R; Mathys JM; Combes V; Grau GE; Bebawy M
Cancer Treat Rev; 2012 May; 38(3):226-34. PubMed ID: 21757296
[TBL] [Abstract][Full Text] [Related]
5. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S; Gualtieri F
Curr Drug Targets; 2006 Jul; 7(7):893-909. PubMed ID: 16842220
[TBL] [Abstract][Full Text] [Related]
6. Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.
Boumendjel A; Baubichon-Cortay H; Trompier D; Perrotton T; Di Pietro A
Med Res Rev; 2005 Jul; 25(4):453-72. PubMed ID: 15834856
[TBL] [Abstract][Full Text] [Related]
7. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.
de Jong MC; Scheffer GL; Broxterman HJ; Hooijberg JH; Slootstra JW; Meloen RH; Kreitman RJ; Husain SR; Joshi BH; Puri RK; Scheper RJ
Clin Cancer Res; 2003 Oct; 9(13):5009-17. PubMed ID: 14581376
[TBL] [Abstract][Full Text] [Related]
9. Modulators of multidrug resistance associated proteins in the management of anticancer and antimicrobial drug resistance and the treatment of inflammatory diseases.
Yang AK; Zhou ZW; Wei MQ; Liu JP; Zhou SF
Curr Top Med Chem; 2010; 10(17):1732-56. PubMed ID: 20645920
[TBL] [Abstract][Full Text] [Related]
10. MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion.
Lorendeau D; Dury L; Nasr R; Boumendjel A; Teodori E; Gutschow M; Falson P; Di Pietro A; Baubichon-Cortay H
Curr Med Chem; 2017; 24(12):1186-1213. PubMed ID: 27855620
[TBL] [Abstract][Full Text] [Related]
11. Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future.
Cole SP
Annu Rev Pharmacol Toxicol; 2014; 54():95-117. PubMed ID: 24050699
[TBL] [Abstract][Full Text] [Related]
12. Decreased functional activity of multidrug resistance protein in primary colorectal cancer.
Micsik T; Lőrincz A; Mersich T; Baranyai Z; Besznyák I; Dede K; Zaránd A; Jakab F; Szöllösi LK; Kéri G; Schwab R; Peták I
Diagn Pathol; 2015 Apr; 10():26. PubMed ID: 25885226
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells.
Lu JF; Pokharel D; Bebawy M
Drug Deliv Transl Res; 2017 Apr; 7(2):276-285. PubMed ID: 28050891
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity.
Wesołowska O; Molnar J; Ocsovszki I; Michalak K
In Vivo; 2009; 23(6):943-7. PubMed ID: 20023237
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1).
Sauna ZE; Peng XH; Nandigama K; Tekle S; Ambudkar SV
Mol Pharmacol; 2004 Mar; 65(3):675-84. PubMed ID: 14978246
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: A historic approach and recent advances.
Stefan SM; Wiese M
Med Res Rev; 2019 Jan; 39(1):176-264. PubMed ID: 29809286
[TBL] [Abstract][Full Text] [Related]
17. High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1).
Peterson BG; Tan KW; Osa-Andrews B; Iram SH
Pharmacol Res; 2017 May; 119():313-326. PubMed ID: 28258008
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF
Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1.
Chang XB
Methods Mol Biol; 2010; 596():223-49. PubMed ID: 19949927
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.
Yuan Y; Cai T; Xia X; Zhang R; Chiba P; Cai Y
Drug Deliv; 2016 Nov; 23(9):3350-3357. PubMed ID: 27098896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
